Century Therapeutics (IPSC) EBITDA Margin (2022 - 2025)
Century Therapeutics' (IPSC) quarterly EBITDA Margin came in at 67.95% in Q1 2025, up 372982.0% year-on-year from N/an in Q1 2024, and up 107.61% on a QoQ basis from 893.46% in Q4 2024.
Century Therapeutics (IPSC) EBITDA Margin (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has 4 years of EBITDA Margin data on file, last reported at 67.95% in Q1 2025.
- On a quarterly basis, EBITDA Margin rose 372982.0% year-over-year to 67.95% in Q1 2025; TTM through Dec 2025 was 15.81%, a 208035.0% increase from a year earlier, with the FY2025 full-year figure at 15.82%, up 208066.0% from the prior year.
- EBITDA Margin for Q1 2025 stood at 67.95%, up from 893.46% in the prior quarter.
- Over the last five years, EBITDA Margin for IPSC reached as high as 67.95% in Q1 2025 and fell as low as 35431.31% in Q2 2023.
- Historically, EBITDA Margin has averaged 8053.42% across 4 years, with a median of 3661.87% in 2024.
- Across the five-year window, EBITDA Margin tumbled 3318554 bps in 2023 and jumped 3092353 bps in 2024, its largest moves.
- Year by year, EBITDA Margin stood at 6392.71% in 2022, then slumped by 155 bps to 16329.1% in 2023, then soared by 95 bps to 893.46% in 2024, then surged by 108 bps to 67.95% in 2025.
- Per Business Quant data, the three most recent EBITDA Margin figures were 67.95% in Q1 2025, 893.46% in Q4 2024, and 4398.1% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 67.95% |
| Dec 31, 2024 | -893.46% |
| Sep 30, 2024 | -4,398.10% |
| Jun 30, 2024 | -4,507.78% |
| Mar 31, 2024 | -3,661.87% |
| Dec 31, 2023 | -16,329.10% |
| Sep 30, 2023 | -24,071.62% |
| Jun 30, 2023 | -35,431.31% |
| Mar 31, 2023 | -1,865.17% |
| Dec 31, 2022 | -6,392.71% |
| Sep 30, 2022 | -1,427.07% |
| Jun 30, 2022 | -2,245.77% |
| Mar 31, 2022 | -3,538.37% |